{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:25:14Z","timestamp":1781670314887,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Women vaccinated through the initial catch-up HPV vaccination programme (2011\/12 to 2013\/14) first became eligible for cervical screening in 2019 at age 25. This study aims to examine the changes in detection of HG cytology outcomes in 25-year-olds screened from 2010 to 2022 compared to population data on HPV vaccination in this group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was an ecological-type study. Cytology results from the CervicalCheck database from 2010 to 2022 (High Grade, Low Grade, and No Abnormality Detected) were plotted against data from the National Immunisation Office on the uptake of HPV vaccinations in females from 2010 to 2022.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Vaccination rates in the catch-up programme were lower (44\u201370%) than for routine HPV immunisation at age 12\/13 in 2010\/11 (81%). The rate of high-grade cytology in 25-year-olds in 2015\u20132018 was 3.7% of all cytology tests taken in this age group. For the corresponding period from 2019 to 2022 (when vaccinated women were attending screening), the average percentage of HG cytology in 25-year-olds was 1.5%, representing a significant reduction in HG cytology proportions (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study provides early evidence of the potential impact of HPV vaccination on cervical disease in the Republic of Ireland. Despite lower vaccination uptake in the initial catch-up group, we are seeing early signs of the positive protective effect of HPV vaccination in women at the time of their first cervical screening test. Plans to incorporate individual-level HPV vaccination status for women on the cervical screening register will allow more detailed assessment of the impact of HPV vaccination.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11845-023-03551-y","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:27:52Z","timestamp":1697686072000},"page":"665-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The effect of HPV vaccination on the rate of high-grade cytology in 25-year-old women attending cervical screening in Ireland"],"prefix":"10.1007","volume":"193","author":[{"given":"Micheal","family":"Rourke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2524-3677","authenticated-orcid":false,"given":"Patricia","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalekan","family":"Popoola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rewhandamzi","family":"Boms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Mason","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Jessop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noirin E.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"3551_CR1","unstructured":"Global Health Objectives (2018) Special call for action: CERVICAL CANCER \u201cAn NCD We Can Overcome\u201d. Geneva, Switzerland. Available at: https:\/\/www.who.int\/director-general\/speeches\/detail\/cervical-cancer-an-ncd-we-can-overcome"},{"key":"3551_CR2","unstructured":"World Health Organisation (2020) Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva, Switzerland"},{"issue":"1","key":"3551_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ijc.26362","volume":"131","author":"A Szarewski","year":"2012","unstructured":"Szarewski A, Poppe WAJ, Skinner SR et al (2012) Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201325 years with and without serological evidence of previous exposure to HPV-16\/18. Int J Cancer 131(1):106\u2013116","journal-title":"Int J Cancer"},{"key":"3551_CR4","unstructured":"Health Protection Surveillance Centre (2013) HPV vaccine uptake in Ireland: 2011\/2012. Dublin. Available at: https:\/\/www.hpsc.ie\/az\/vaccinepreventable\/vaccination\/immunisationuptakestatistics\/hpvtdapmencmenacwyuptakestatistics\/hpvimmunisationuptakereports2011-2018\/File,14255,en.pdf"},{"issue":"10135","key":"3551_CR5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/S0140-6736(18)30854-7","volume":"391","author":"B Corcoran","year":"2018","unstructured":"Corcoran B, Clarke A, Barrett T (2018) Rapid response to HPV vaccination crisis in Ireland. Lancet 391(10135):2103","journal-title":"Lancet"},{"issue":"14","key":"3551_CR6","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jama.2022.17191","volume":"328","author":"D Khullar","year":"2022","unstructured":"Khullar D (2022) Social media and medical misinformation: confronting new variants of an old problem. JAMA 328(14):1393\u20131394","journal-title":"JAMA"},{"key":"3551_CR7","unstructured":"Health Service Executive (2022) CervicalCheck programme report September 2017\u2013March 2020. Dublin. Available at: https:\/\/assets.hse.ie\/media\/documents\/CervicalCheck_Programme_Report_2017-2020.pdf"},{"issue":"6","key":"3551_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M (2023) Cervical cancer screening: a review. JAMA 330(6):547\u2013558","journal-title":"JAMA"},{"key":"3551_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bpobgyn.2020.02.009","volume":"65","author":"A Athanasiou","year":"2020","unstructured":"Athanasiou A, Bowden S, Paraskevaidi M et al (2020) HPV vaccination and cancer prevention. Best Pract Res Clin Obstet Gynaecol 65:109\u2013124","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3551_CR10","unstructured":"Health Protection Surveillance Centre (2014) HPV vaccine uptake in Ireland: 2012\/2013. Dublin. Available at: https:\/\/www.hpsc.ie\/az\/vaccinepreventable\/vaccination\/immunisationuptakestatistics\/hpvtdapmencmenacwyuptakestatistics\/hpvimmunisationuptakereports2011-2018\/File,14786,en.pdf"},{"key":"3551_CR11","unstructured":"Health Protection Surveillance Centre (2015) HPV vaccine uptake in Ireland: 2013\/2014. Dublin. Available at: https:\/\/www.hpsc.ie\/az\/vaccinepreventable\/vaccination\/immunisationuptakestatistics\/hpvtdapmencmenacwyuptakestatistics\/hpvimmunisationuptakereports2011-2018\/File,15198,en.pdf"},{"key":"3551_CR12","doi-asserted-by":"publisher","unstructured":"Arbyn M, Xu L, Simoens C, Martin-Hirsch PP (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 5(5):CD009069. https:\/\/doi.org\/10.1002\/14651858.CD009069.pub3. PMID: 29740819; PMCID: PMC6494566","DOI":"10.1002\/14651858.CD009069.pub3"},{"issue":"14","key":"3551_CR13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei J, Ploner A, Elfstrom KM et al (2020) HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 383(14):1340\u20131348","journal-title":"N Engl J Med"},{"key":"3551_CR14","unstructured":"Risk-based Screening for Cervical Cancer Consortium (2023) Risk-based screening for cervical cancer. Available from: https:\/\/www.riscc-h2020.eu\/"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03551-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T04:03:25Z","timestamp":1711339405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03551-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3551"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03551-y","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"29 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}